Helseth A, Mørk S J
Norwegian Cancer Registry, Institute for Epidemiological Cancer Research, Montebello, Oslo.
APMIS. 1989 Jun;97(6):547-55.
Data were analysed from 4859 patients with different histological types of intracranial glioma registered by the Norwegian Cancer Registry between 1955 and 1984. Glioblastoma comprised 57.9% of all cases. The second most common primary brain tumour was astrocytoma (19.0%), then mixed glioma (9.2%), oligodendroglioma (7.9%), medulloblastoma (3.1%) and ependymoma (2.9%). A primary brain tumour in a child is approximately twice as likely to be an astrocytoma as a medulloblastoma. The age-specific incidence for glioblastoma increases with age, whereas the incidence of astrocytoma and oligodendroglioma peaks at middle age. Both glioblastoma and astrocytoma showed increased incidence rates over the study period and this was most pronounced in the age-group above 60 years. The prognosis for gliomas varied with age at time of diagnosis, generally being better the younger the patient. For oligodendroglioma patients, survival prospects were independent of age at time of diagnosis. The best prognosis was seen in patients up to 30 years with astrocytoma. Applied in epidemiology, the data indicate that astrocytoma, oligodendroglioma, mixed glioma and ependymoma may be treated as a group which should be separated from both glioblastoma and medulloblastoma.
对挪威癌症登记处1955年至1984年间登记的4859例不同组织学类型的颅内胶质瘤患者的数据进行了分析。胶质母细胞瘤占所有病例的57.9%。第二常见的原发性脑肿瘤是星形细胞瘤(19.0%),其次是混合性胶质瘤(9.2%)、少突胶质细胞瘤(7.9%)、髓母细胞瘤(3.1%)和室管膜瘤(2.9%)。儿童原发性脑肿瘤是星形细胞瘤的可能性大约是髓母细胞瘤的两倍。胶质母细胞瘤的年龄特异性发病率随年龄增长而增加,而星形细胞瘤和少突胶质细胞瘤的发病率在中年达到峰值。在研究期间,胶质母细胞瘤和星形细胞瘤的发病率均有所上升,在60岁以上年龄组最为明显。胶质瘤的预后随诊断时的年龄而异,一般来说患者越年轻预后越好。对于少突胶质细胞瘤患者,生存前景与诊断时的年龄无关。30岁以下的星形细胞瘤患者预后最佳。在流行病学中应用这些数据表明,星形细胞瘤、少突胶质细胞瘤、混合性胶质瘤和室管膜瘤可被视为一组,应与胶质母细胞瘤和髓母细胞瘤区分开来。